The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Restech sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Restech Srl (Restech) is a medical device company that develops and commercializes respiratory devices. The company uses forced oscillation technique (FOT) to manufacture its products. Its product portfolio comprises of Pulmonary Oscillometry Resmon Pro Full and Resmon pro diary. These products are used for the functional assessment of patients with respiratory diseases, and gathering, analyzing, interpreting and sharing their respiratory measurements with stakeholders. It offers instruments that analyze standard breathing-pattern indices, expiratory flow limitation, pulmonary obstruction and heterogeneity of the obstruction, bronchial-reversibility and bronchial-challenge evaluations for comparative diagnosis. Restech provides products which find application in respiratory pathophysiology, pediatrics, sports medicine, drug-effectiveness assessments, inpatient treatment and research hospitals, clinic diagnosis and research centers. The company is a spin-off of Milan Polytechnic. Restech is headquartered in Milan, Italy.
The key metrics of Restech related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Restech is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Restech.
For a detailed understanding of the performance of Restech, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
